HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Rhumbline Advisers

Rhumbline Advisers grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.2% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 327,226 shares of the company's stock after purchasing an additional 13,142 shares during the period. Rhumbline Advisers owned approximately 0.14% of HCA Healthcare worth $113,073,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Principal Financial Group Inc. increased its position in shares of HCA Healthcare by 120.1% during the fourth quarter. Principal Financial Group Inc. now owns 873,775 shares of the company's stock worth $262,264,000 after acquiring an additional 476,756 shares during the period. Deroy & Devereaux Private Investment Counsel Inc. increased its holdings in HCA Healthcare by 1.6% in the fourth quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 120,812 shares of the company's stock valued at $36,262,000 after buying an additional 1,931 shares during the last quarter. Spire Wealth Management increased its holdings in HCA Healthcare by 23.0% in the fourth quarter. Spire Wealth Management now owns 9,913 shares of the company's stock valued at $2,975,000 after buying an additional 1,851 shares during the last quarter. Financial Strategies Group Inc. increased its holdings in HCA Healthcare by 17.3% in the fourth quarter. Financial Strategies Group Inc. now owns 23,694 shares of the company's stock valued at $7,175,000 after buying an additional 3,495 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in HCA Healthcare by 4.5% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 19,448 shares of the company's stock valued at $5,864,000 after buying an additional 840 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA traded down $0.31 during mid-day trading on Thursday, reaching $381.35. 1,058,710 shares of the company's stock were exchanged, compared to its average volume of 1,441,924. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company has a 50-day simple moving average of $354.51 and a two-hundred day simple moving average of $331.38. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a market cap of $91.74 billion, a price-to-earnings ratio of 17.36, a PEG ratio of 1.10 and a beta of 1.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. The business had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company's revenue was up 5.7% on a year-over-year basis. During the same period last year, the company posted $5.36 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio is presently 12.81%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on HCA shares. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Guggenheim started coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating for the company. Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their target price for the stock from $320.00 to $385.00 in a research note on Thursday, May 29th. Finally, Robert W. Baird restated a "neutral" rating and issued a $336.00 price objective (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Seven investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and an average price target of $388.80.

Insider Activity

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.